Efficacy and Safety of Standard Corneal Cross-Linking Procedures Performed With Short Versus Standard Riboflavin Induction: A Save Sight Keratoconus Registry Study

被引:5
|
作者
Benito-Pascual, Blanca [1 ,7 ]
Kandel, Himal [1 ,2 ]
Abbondanza, Marco [3 ,4 ]
Mills, Richard [5 ]
Sullivan, Laurence [6 ]
Watson, Stephanie L. [1 ,2 ]
机构
[1] Sydney Eye Hosp, Sydney, Australia
[2] Univ Sydney, Save Sight Inst, Fac Med & Hlth, Sydney, Australia
[3] Abbondanza Eye Ctr, Rome, Italy
[4] Abbondanza Eye Ctr, Milan, Italy
[5] Flinders Med Ctr, Adelaide, Australia
[6] Bayside Eye Specialists, Melbourne, Australia
[7] 714 23 Shelley ST, Sydney, NSW 2000, Australia
关键词
keratoconus; riboflavin; registries; disease progression; corneal cross-linking; FLUENCE;
D O I
10.1097/ICO.0000000000003058
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose:The objective of this study was to compare the effectiveness and safety of short versus standard riboflavin induction times in cross-linking (CXL) for keratoconus.Methods:A retrospective comparative study was conducted with data from the Save Sight Keratoconus Registry. Inclusion criteria were epithelium-off technique, standard UVA CXL protocol (3 mW/cm(2) for 30 minutes), riboflavin induction for 15 minutes (short) or 30 minutes (standard), and 1 year of follow-up data after CXL. Outcome measures included changes in best-corrected visual acuity (BCVA), keratometry in the steepest meridian (K2), maximum keratometry (Kmax), thinnest pachymetry (TCT), and adverse events. Analysis was conducted using mixed-effects regression models adjusted for age, sex, visual acuity, keratometry, pachymetry, practice, and eye laterality.Results:Two hundred eighty eyes (237 patients; mean, 27.3 +/- 10.5 years old; 30% female) were included. The riboflavin induction time was short in 102 eyes (82 patients) and standard in 178 eyes (155 patients). The baseline characteristics (sex, mean age, BCVA, keratometry, and pachymetry [TCT]) were similar between the groups. At the 1-year follow-up visit, no statistically significant differences were observed in flattening in K2 and improvement in BCVA. Greater Kmax flattening [-1.5 diopters (D) vs. -0.5D, P = 0.031] and a greater proportion of >2% increase in TCT (23.5 vs. 11.3, P = 0.034) and haze (29 vs. 15, P = 0.005) were observed with short riboflavin induction.Conclusions:Short and standard riboflavin induction times achieved similar degrees of flattening in K2 and improvement in vision. Greater improvements in Kmax and TCT were seen with short riboflavin times; however, this group had higher rates of haze.
引用
收藏
页码:326 / 331
页数:6
相关论文
共 50 条
  • [1] Comparison of Standard versus Accelerated corneal collagen cross-linking for keratoconus: one-year outcomes from Save Sight Keratoconus Registry study
    Kandel, Himal
    Nguyen, Vuong
    Ferdi, Alex
    Gupta, Aanchal
    Abbondanza, Marco
    Sullivan, Laurence
    Apel, Andrew
    Mills, Richard A.
    Chen, Jern Yee
    Watson, Adam
    Petsoglou, Constantinos
    Downie, Nicholas
    Watson, Stephanie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [2] The comparative efficacy and safety of hypotonic vs isotonic riboflavin for corneal cross-linking in 'thick' keratoconic corneas: a Save Sight Keratoconus Registry study
    Watson, Stephanie L.
    Gupta, Aanchal
    Mills, Richard A.
    Chen, Jern Yee
    Sullivan, Laurence
    Apel, Andrew
    Watson, Adam
    Abbondanza, Marco
    Kandel, Himal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [3] Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry
    Kandel, Himal
    Abbondanza, Marco
    Gupta, Aanchal
    Mills, Richard
    Watson, Adam S.
    Petsoglou, Constantinos
    Kerdraon, Yves
    Watson, Stephanie L.
    EYE, 2024, 38 (01) : 95 - 102
  • [4] Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry
    Himal Kandel
    Marco Abbondanza
    Aanchal Gupta
    Richard Mills
    Adam S. Watson
    Constantinos Petsoglou
    Yves Kerdraon
    Stephanie L. Watson
    Eye, 2024, 38 : 95 - 102
  • [5] Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: Two-year outcomes from the save sight keratoconus registry
    Watson, Stephanie L.
    Gupta, Aanchal
    Abbondanza, Marco
    Sullivan, Laurence
    Apel, Andrew
    Kandel, Himal
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 864 - 864
  • [6] Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study
    Ferdi, Alex C.
    Kandel, Himal
    Vuong Nguyen
    Tan, Jeremy
    Arnalich-Montiel, Francisco
    Abbondanza, Marco
    Watson, Stephanie L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (01): : 9 - 18
  • [7] Ten-year outcomes of corneal cross-linking: A Save Sight Keratoconus Registry study
    Watson, Stephanie
    Abbondanza, Marco
    Samarawickrama, Chameen
    Gupta, Aanchal
    Arnalich, Francisco
    Kerdraon, Yves
    Yeung, Season
    Apel, Andrew
    Ang, Andrea
    Kandel, Himal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [8] 5-year outcomes of corneal cross-linking: A Save Sight Keratoconus Registry study
    Ferdi, Alex
    Nguyen, Vuong
    Kandel, Himal
    Tan, Jeremy
    Arnalich Montiel, Francisco
    Abbondanza, Marco
    Watson, Stephanie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [9] Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study
    Kandel, Himal
    Nguyen, Vuong
    Ferdi, Alex C.
    Gupta, Aanchal
    Abbondanza, Marco
    Sullivan, Laurence
    Apel, Andrew
    Watson, Stephanie L.
    CORNEA, 2021, 40 (12) : 1581 - 1589
  • [10] The long-term outcomes from corneal cross-linking: A save sight keratoconus registry study
    Watson, Stephanie
    Ferdi, Alexander
    Vuong Nguyen
    Abbondanza, Marco
    Garcia, Marco
    Kandel, Himal
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 36 - 37